(24/7 MARKET NEWS) – (24/7 MARKET NEWS) – We covered that Unicycive Therapeutics (NASDAQ: UNCY) announced an up to $130 million funding agreement on Monday, when it was trading at $1.06 and its 52-week high was $1.64.
Unicycive is trading at $2.17, up $0.11 (+5.34%), on 570 thousand premarket shares.
Its 52-week trading range is $0.4004 to $2.24. If it can clear yesterday’s $2.24 high, on strong trading volume, it may try to reverse the December 2021 move to the $3 level.
24/7 MARKET NEWS, INC Disclaimer
24/7 MARKET NEWS (“24/7 MN”) is dedicated to covering various underreported segments of the stock markets. Our goal is to help you to better understand these markets, but 24/7 MN is neither an investment advisor nor a financial advisor, and no information provided here is to be interpreted as a suggestion to buy or sell stocks or other investment products. All opinions, news, research, analysis, prices or other information contained on 247marketnews.com, its press releases, or other services are provided for educational purposes only and do not constitute investment advice. You are solely responsible for the investment decisions you make.
Please go to www.247marketnews.com or https://www.247marketnews.com/terms-disclaimer/ for further information.